I am practicing in a public/socialist system and can relate to her care. The potential for oncology is potentially paradigm changing. For the area that have not responded SABR - SRS - SBRT or low dose conformal for larger volumes could be given. It would be an interesting research study to see how this would fit into the Oligometastatic Paradigm.
Market Data 
Markets
AI
